Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Doxorubicin (liposomal) 50mg powder and solvent for suspension for infusion vials |
| BNF code | 0801020K0AAAHAH |
| Virtual Therapeutic Moiety | Doxorubicin (liposomal) |
| Abbreviated name | Doxorubicin (liposomal) 50mg inf vials |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 12 Feb 2010 |
| Previous name | Doxorubicin (liposomal) 50mg powder and solvent for suspension for injection vials |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products not Available |
| Non-availability status date | 8 Oct 2019 |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | vial |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Doxorubicin citrate complex liposomal |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 90875009 |
| Strength value numerator | 50.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | suspensioninfusion.intravenous |
| Dose Form | |
| Formulation | Powder and solvent for suspension for infusion |
| Drug Route | |
| Route | Intravenous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Virtual Medicinal Product Packs | |
| Doxorubicin (liposomal) 50mg powder and solvent for suspension for infusion vials 2 vial | |
dm+d data retrieved from TRUD: release NHSBSA_2.2.0_20250217000001, imported on 18th February 2025 at 03:53:40.